As of 2024-12-14, the Relative Valuation of Dechra Pharmaceuticals PLC (DPH.L) is (488.29) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 3,866.00 GBP, the upside of Dechra Pharmaceuticals PLC based on Relative Valuation is -112.6%.
The range of the Relative Valuation is (452.88) - (506.31) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.5x - 20.7x | 19.4x |
| Forward P/E multiples | 18.5x - 22.9x | 20.5x |
| Fair Price | (452.88) - (506.31) | (488.29) |
| Upside | -111.7% - -113.1% | -112.6% |
| Date | P/E |